Tseng et al 202 modified the surface of Adriamycin-loaded liposomes with Tat, which increased the uptake of Adriamycin in cancer cells by nearly 12 times, thus significantly enhancing the antitumor activity of Adriamycin
BPC-157 and TB-500 (thymosin -4) are research compounds with no approved human or veterinary drug product
Reliable service and product Shipping was pretty quick even with the holiday weekend
Our team is available to help you understand the program and next steps
A second family, BPC-157 and TB-500, targets tissue repair rather than the GH axis: BPC-157 is proposed to work through angiogenesis, nitric-oxide signaling, and anti-inflammatory activity, while TB-500 binds actin to promote cell migration, blood-vessel formation, and collagen deposition